Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease

Lancet

Volumn 351, Issue 9120, 1998, Pages 1930-1931

  Taïeb, Julien ^b   Mathurin, Philippe ^b   Poynard, Thierry ^b   Gougerot Pocidalo, Marie Anne ^b   Chollet Martin, Sylvie ^a  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; MESSENGER RNA;

ALCOHOL LIVER DISEASE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HUMAN; KUPFFER CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RNA SPLICING;

EID: 0032572341     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78614-1     Document Type: Article

References (4)

1. 1 Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO61/fas) receptor and ligand in liver damage. J Exp Med 1995; 182: 1223-30.
2. 2 Hiramatsu N, Hayashi N, Katayama K, et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354-59.
3. 3 Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum. Nat Med 1996; 2: 317-22.
4. 4 Midis G, Shen Y, Owen-Scaub LB. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Res 1996; 56: 3870-74.